Unknown

Dataset Information

0

A Novel Hybrid Cytokine IL233 Mediates regeneration following Doxorubicin-Induced Nephrotoxic Injury.


ABSTRACT: Kidney injury, whether due to ischemic insults or chemotherapeutic agents, is exacerbated by inflammation, whereas Tregs are protective. We recently showed that IL-2 and IL-33, especially as a hybrid cytokine (IL233 - bearing IL-2 and IL-33 activities in one molecule), potentiated Tregs and group 2 innate lymphoid cells (ILC2) to prevent renal injury. Recent studies have indicated a reparative function for Tregs and ILC2. Here, using doxorubicin-induced nephrotoxic renal injury model, we investigated whether IL233 administration either before, late or very late after renal injury can restore kidney structure and function. We found that IL233 treatment even 2-weeks post-doxorubicin completely restored kidney function accompanied with an increase Treg and ILC2 in lymphoid and renal compartments, augmented anti-inflammatory cytokines and attenuated proinflammatory cytokine levels. IL233 treated mice had reduced inflammation, kidney injury (Score values - saline: 3.34?±?0.334; IL233 pre: 0.42?±?0.162; IL233 24?hrs: 1.34?±?0.43; IL233 1 week: 1.2?±?0.41; IL233 2 week: 0.47?±?0.37; IL233 24?hrs?+?PC61: 3.5?±?0.74) and fibrosis in all treatment regimen as compared to saline controls. Importantly, mice treated with IL233 displayed a reparative program in the kidneys, as evidenced by increased expression of genes for renal progenitor-cells and nephron segments. Our findings present the first evidence of an immunoregulatory cytokine, IL233, which could be a potent therapeutic strategy that augments Treg and ILC2 to not only inhibit renal injury, but also promote regeneration.

SUBMITTER: Sabapathy V 

PROVIDER: S-EPMC6397151 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

A Novel Hybrid Cytokine IL233 Mediates regeneration following Doxorubicin-Induced Nephrotoxic Injury.

Sabapathy Vikram V   Cheru Nardos Tesfaye NT   Corey Rebecca R   Mohammad Saleh S   Sharma Rahul R  

Scientific reports 20190301 1


Kidney injury, whether due to ischemic insults or chemotherapeutic agents, is exacerbated by inflammation, whereas Tregs are protective. We recently showed that IL-2 and IL-33, especially as a hybrid cytokine (IL233 - bearing IL-2 and IL-33 activities in one molecule), potentiated Tregs and group 2 innate lymphoid cells (ILC2) to prevent renal injury. Recent studies have indicated a reparative function for Tregs and ILC2. Here, using doxorubicin-induced nephrotoxic renal injury model, we investi  ...[more]

Similar Datasets

| S-EPMC6509327 | biostudies-literature
| S-EPMC5576940 | biostudies-literature
| S-EPMC6538350 | biostudies-literature
| S-EPMC2739827 | biostudies-literature
| S-EPMC10421787 | biostudies-literature
| S-EPMC5543921 | biostudies-literature
| S-EPMC10350186 | biostudies-literature
| S-EPMC6459708 | biostudies-literature
| S-EPMC7865186 | biostudies-literature
| S-EPMC2753793 | biostudies-literature